Effective with date of service April 17, 2023, NC Medicaid covers bevacizumab-adcd injection, for intravenous use (Vegzelma)
Blog Entry List
Updates include updated policies on Acuity Tiers, Acuity-Based Contacts and Contact Monitoring.
Effective May 30, 2023, NC Medicaid covers aripiprazole extended-release injectable suspension, for intramuscular use (Abilify Asimtufii).
Effective with date of service May 15, 2023, NC Medicaid covers pegfilgrastim-pbbk injection, for subcutaneous use (Fylnetra).
Effective with date of service April 21, 2023, NC Medicaid covers paclitaxel protein-bound particles for injectable suspension, (albumin-bound)
The North Carolina Department of Health and Human Services recently awarded Acentra Health the contract as the Comprehensive Independent Assessment Entity (CIAE) for NC Medicaid.
Effective July 1, 2023, NC Medicaid has increased the Medicaid rate for Maternal Bundled Payments for pregnancy care.
A draft application for § 1915 (c) NC Innovation Waiver is posted for a 30-day public comment period.
This bulletin provides details on coverage for COVID-19 Vaccines and COVID-19 Counseling after the ending of the Federal Public Health Emergency.
Beneficiaries who will be covered by the Tailored Plans will continue to receive care as they do today.
Effective Jan. 1, 2023, the location field must have a valid value of 1 or 2.
The report and instructions for completing the report are updated to capture additional information needed for Credit Balance Audits
Includes an overview of the newest Center for Medicare and Medicaid Innovation payment model for Medicare, NC Medicaid’s involvement and timelines.
Allows Home and Community Based Services for individuals with behavioral health, intellectual/developmental disabilities and traumatic brain injury.
New Temporary/Interim Estimated Budget Increases Added July 1, 2023.